Palliative care provider attitudes toward existential distress and treatment with psychedelic-assisted therapies
Halsey Niles, Colleen Fogg, Ben Kelmendi, Mark Lazenby
BMC Palliative Care December 26, 2021 DOI: 10.1186/s12904-021-00889-x via DOAJ
Summary
AI-generated from the abstractPalliative care clinicians view existential distress as a common and often inadequately treated psychosocial-spiritual problem that resists purely medical approaches. They see psychedelic-assisted therapies (PAT) as a potentially powerful tool for refractory existential distress but believe a stronger evidence base is needed. Because PAT do not fit existing treatment models, barriers remain, including stigma and limited education about their medical use. Larger clinical trials and educational outreach are needed to clarify treatment targets and address safety concerns, and integration into palliative care should emphasize collaboration with spiritual care and mental health providers while addressing equitable access.
Study at a glance
| Characteristics | Qualitative study Peer reviewed |
|---|---|
| Sample size | 19 |
| Population | Palliative care clinicians (physicians, advanced practice nurses, chaplains, social workers, psychologist) from multiple US sites |
| Topics | End-of-life distress Psilocybin Psychedelic-assisted therapy |
| Keywords | Demoralization Psychedelic-assisted therapy psilocybin Powerful future tool Severe spiritual distress Refractory existential distress |
| Key finding | Palliative care clinicians view PAT as a promising but not yet ready tool for treating existential distress, citing the need for a stronger evidence base and resolution of barriers related to stigma, education, and integration into existing care models. |
Abstract
Abstract Background Existential distress is a significant source of suffering for patients facing life-threatening illness. Psychedelic-Assisted Therapies (PAT) are novel treatments that have shown promise in treating existential distress, but openness to providing PAT may be limited by stigma surrounding psychedelics and the paucity of education regarding their medical use. How PAT might be integrated into existing treatments for existential distress within palliative care remains underexplored. Methods The present study aimed to elucidate the attitudes of palliative care clinicians regarding treatments for existential distress, including PAT. We recruited palliative care physicians, advanced practice nurses, and spiritual and psychological care providers from multiple US sites using purposive and snowball sampling methods. Attitudes toward PAT were unknown prior to study involvement. Semi-structured interviews targeted at current approaches to existential distress and attitudes toward PAT were analyzed for thematic content. Results Nineteen respondents (seven physicians, four advanced practice nurses, four chaplains, three social workers, and one psychologist) were interviewed. Identified themes were 1) Existential distress is a common experience that is frequently insufficiently treated within the current treatment framework; 2) Palliative care providers ultimately see existential distress as a psychosocial-spiritual problem that evades medicalized approaches; 3) Palliative care providers believe PAT hold promise for treating existential distress but that a stronger evidence base is needed; 4) Because PAT do not currently fit existing models of existential distress treatment, barriers remain. Conclusions PAT is seen as a potentially powerful tool to treat refractory existential distress. Larger clinical trials and educational outreach are needed to clarify treatment targets and address safety concerns. Further work to adapt PAT to palliative care settings should emphasize collaboration with spiritual care as well as mental health providers and seek to address unresolved concerns about equitable access.